retatrutide fatty liver study 🧬 BREAKTHROUGH IN HEALTH? Scientists have reported that Retatrutide, an investigational metabolic therapy, reduced liver fat by up to 82% in an early clinical involving people with liver Triple hormone receptor agonist retatrutide

But the interesting thing about the new study is that the researchers used a low dose of retatrutide one that was too low to cause weight loss

Its kind of almost like a road map for future studies, but it also gives me confirmation of some of the hunches Ive had, and maybe it might affect some of my decision making with patients, said Dr

Marketing authorisations granted in 2025

GLP-1 is a hormone produced in the gut that stimulates insulin secretion and helps regulate blood sugar levels

Personalized treatment is important, as age, sex, and even lifestyle can change how someone reacts to retatrutide

This they investigated by testing the peptides in plasma collected from six healthy individuals both when they fasted and had a mixed meal (rskov, Holst